LOS ANGELES, May 21 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that revenues for the first quarter of 2008, ended March 31, totaled $1.43 million. Revenues from the Company's primary umbilical cord blood storage business increased 10 percent while reducing marketing and advertising costs. Overall revenues decreased because of a change in business strategies at the Company's advertising subsidiary, Rainmakers International, to focus on low cost, high volume, annuity based advertising.
"While there are areas to improve in the quarter, we are especially pleased that Gross Profit increased from 35 percent of revenues to 45 percent, because a significantly higher proportion of revenues are coming from the higher margin umbilical cord blood processing and storage business," said Matthew Schissler, CEO, Cord Blood America. "We are confident that our continued focus on recurring revenue models for both Rain and the umbilical cord blood business will pay dividends in the near future."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of
CorCell, which facilitates umbilical cord blood stem cell preservation for
expectant parents and their children. Its mission is to be the most
respected stem cell preservation company in the industry. Collected through
a safe and non-invasive process, cord blood stem cells offer a powerful and
potentially life-saving resource for treating a growing number of ailments,
including cancer, leukemia, blood, and immune disorders. To find out more
about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our
website at http://www.corcell.com. For investor information, visit
E & E Communications
|SOURCE Cord Blood America, Inc.|
Copyright©2008 PR Newswire.
All rights reserved